EQS-AGM: Fresenius Medical Care AG & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 14.07.2023 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
|
EQS-News: Fresenius Medical Care AG Co. KGaA
/ Announcement of the Convening of the General Meeting
Fresenius Medical Care AG Co. KGaA announces the convening of the General
Meeting. Please find the full text of the announcement here: English: https://dgap.hv.eqs.com/230512046165/en/FME_-_EGM_-_Convocation_-_EN_-_Banz_Upload_.pdf
05.06.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fresenius Medical Care AG Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Phone: | +49 6172 6095306 |
| Fax: | +49 6172 6092301 |
| E-mail: | [email protected] |
| Internet: | https://www.freseniusmedicalcare.com/de/hauptversammlung/ |
| ISIN: | DE0005785802, US3580291066 |
| WKN: | 578580 |
| Listed: | XETRA, NYSE |
| End of News | EQS News Service |
|
|
1649673 05.06.2023 CET/CEST
Fresenius Medical Care AG & Co KGaA ST Aktie
Bei der Aktie stehen derzeit 4 Buy-Einschätzungen 0 Sell-Einschätzungen gegenüber. Das Sentiment ist also durchaus positiv.
Für Fresenius Medical Care AG & Co KGaA ST sieht die Community ein Kursziel von 50 €, was eine erhebliche Steigerung um über 20% gegenüber dem aktuellen Kurs von 35.78 € bedeutet.
